ARCHIVES

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

New Frederick RFP Out May 14; Five contracts To Be Awarded, Each For Five to Seven Years

May 2, 1986

New AIDs System For Classification Increase By 1% Cases Reported

August 1, 1986

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Symposium Addresses FCC issues

February 21, 1986